PEN Q4 2022 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$221M+8.4% YoY

Gross Profit

$138M62.6% margin

Operating Income

$5M2.2% margin

Net Income

$4M1.8% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+3.5%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$372M

Stockholders' Equity

$999M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$221M	$204M	+8.4%
Gross Profit	$138M	$125M	+10.3%
Operating Income	$5M	-$40M	+112.1%
Net Income	$4M	-$25M	+115.7%

Revenue Segments

Peripheral Vascular

$130M59%

Neuro

$92M41%

Geographic Segments

UNITED STATES

$157M71%

Other Non-US

$64M29%